HLA-DR (L243) Antibody sc-18875 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemHLA-DR (L243) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-18875
Antibody TypePrimary Antibodies
Quantity200 µg/ml
ApplicationsIF, IHC(P), FCM
CloneL243
Reactivityhuman
ClonalityMonoclonal
FormatPurified
Hostmouse
Conjugate/TagUnconjugated
TargetHLA-DR
IsotypeIgG2a

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Crosstalk between autophagy and apoptosis in initiating antitumor immune responses in human lymphoma cellsExploration of ImmunologySeptember 11, 2025Kayce Blumenstock, Faisal F. Y. Radwan, Vandana Zaman, Narendra L. Banik, Azizul Haqueat room temperature. The cells were then incubated with 1:100 HLA-DR L243 mouse monoclonal IgG (Cat #sc-18875 Santa Cruz Biotechnology, Dallas, TX) primary antibody at 4°C for overnight. The next day after a 3

(2) Hypochlorous acid-modified human serum albumin suppresses MHC class II - dependent antigen presentation in pro-inflammatory macrophagesRedox biologyJuly 1, 2021Ulfig A, Bader V, Varatnitskaya M, Lupilov N, Winklhofer KF, Leichert LI.

(3) Palmitoylated mNeonGreen Protein as a Tool for Visualization and Uptake Studies of Extracellular VesiclesMembranesNovember 27, 2020Wąchalska M, Rychłowski M, Grabowska K, Kowal K, Narajczyk M, Bieńkowska-Szewczyk K, Lipińska AD.

(4) Alphaherpesvirus gB Homologs Are Targeted to Extracellular Vesicles, but They Differentially Affect MHC Class II MoleculesVirusesApril 10, 2020Grabowska K, Wąchalska M, Graul M, Rychłowski M, Bieńkowska-Szewczyk K, Lipińska AD.

(5) Amelogenin Downregulates Interferon Gamma-Induced Major Histocompatibility Complex Class II Expression Through Suppression of Euchromatin Formation in the Class II Transactivator Promoter IV Region in MacrophagesFrontiers in immunologyJanuary 1, 2020Yotsumoto K, Sanui T, Tanaka U, Yamato H, Alshargabi R, Shinjo T, Nakao Y, Watanabe Y, Hayashi C, Taketomi T, et al.the cell surface expression of MHC II molecules, cells were stained with primary anti-HLA-DR (L243): sc-18875 (1:250; Santa Cruz Biotechnology, Inc.). Subsequently, Alexa Fluor® 594 goat anti-mouse IgG (minimal x-reactivity

(6) Infrapatellar Fat Pad Stem Cells Responsiveness to Microenvironment in Osteoarthritis: From Morphology to FunctionFrontiers in cell and developmental biologyJanuary 1, 2019Stocco E, Barbon S, Piccione M, Belluzzi E, Petrelli L, Pozzuoli A, Ramonda R, Rossato M, Favero M, Ruggieri P, et al.anti-human CD105 (Endoglin P3D1),sc-18838,"Santa Cruz Biotechnology, Inc" PE mouse anti-human HLA-DR (L243),sc-18875,"Santa Cruz Biotechnology, Inc" A350 anti-human IL1R1,bs-2594R,Bioss Rabbit anti-human IL6R,AB-83485,Immunological

(7) Mesenchymal stem cells derived from inflamed dental pulpal and gingival tissue: a potential application for bone formationStem cell research & therapyAugust 1, 2017Tomasello L, Mauceri R, Coppola A, Pitrone M, Pizzo G, Campisi G, Pizzolanti G, Giordano C., r.t." "CD45, surface","Santa Cruz, sc-28369",1:50,"o/n , r.t." "HLA-DR, surface","Santa Cruz , sc-18875",1:50,"o/n , r.t." Secondary antibody,Secondary antibody,Secondary antibody,Secondary antibody AlexaFluor

(8) Donor-dependent variances of human adipose-derived stem cells in respect to the in-vitro endothelial cell differentiation capabilityAdipocyteJanuary 2, 2017Ell J, Regn S, Buchberger AM, von Bomhard A, Stark T, Schantz JT, Storck K.

(9) Donor age and long-term culture do not negatively influence the stem potential of limbal fibroblast-like stem cellsStem cell research & therapyJune 13, 2016Tomasello L, Musso R, Cillino G, Pitrone M, Pizzolanti G, Coppola A, Arancio W, Di Cara G, Pucci-Minafra I, Cillino S, et al.Primary antibody/localization marker,Code number,Dilution,Incubation "HLA-DR, surface","Santa Cruz, sc-18875",1:50,"o/n, r.t." "CD34, surface","Santa Cruz, sc-19621",1:50,"o/n, r.t." "CD45, surface","Santa Cruz,

(10) Expression of MIF and CD74 in leukemic cell lines: correlation to DR expression destinyBiological chemistryJune 1, 2016Georgouli M, Papadimitriou L, Glymenaki M, Patsaki V, Athanassakis I.

(11) Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer TherapiesCancer immunology researchNovember 1, 2015Hossain F, Al-Khami AA, Wyczechowska D, Hernandez C, Zheng L, Reiss K, Valle LD, Trillo-Tinoco J, Maj T, Zou W, et al.

(12) Efficient induction of anti-tumor immune response in esophageal squamous cell carcinoma via dendritic cells expressing MAGE-A3 and CALR antigensCellular immunologyJune 1, 2015Liu X, Song N, Liu Y, Liu Y, Li J, Ding J, Tong Z.

(13) Long-term Supplementation With n-6 and n-3 PUFAs Improves Moderate-to-Severe Keratoconjunctivitis Sicca: A Randomized Double-Blind Clinical TrialCorneaOctober 1, 2013Sheppard JD Jr, Singh R, McClellan AJ, Weikert MP, Scoper SV, Joly TJ, Whitley WO, Kakkar E, Pflugfelder SC.

(14) DOα⁻β⁺ expression in favor of HLA-DR engagement in exosomesImmunobiologyAugust 1, 2013Papadimitriou L, Zerva I, Georgouli M, Makatounakis T, Papamatheakis J, Athanassakis I.

(15) Foreign body-type multinucleated giant cells induced by interleukin-4 express select lymphocyte co-stimulatory molecules and are phenotypically distinct from osteoclasts and dendritic cellsExperimental and molecular pathologyDecember 1, 2011McNally AK, Anderson JM.(sc-1635), B7-H1 (R and D Systems, Minneapolis, MN, AF-156), B7-H2 (AF-165), CD98 (sc-7095) and HLA-DR (sc-18875). Components of interest were detected with secondary antibodies conjugated to AlexaFluor568 (Molecular Probes

(16) Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infectionJournal of virologyApril 1, 2008Jenkins C, Garcia W, Godwin MJ, Spencer JV, Stern JL, Abendroth A, Slobedman B.

(17) Neural cell adhesion molecule expression on renal interstitial cellsNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal AssociationJune 1, 2007Marković-Lipkovski J, Müller CA, Klein G, Flad T, Klatt T, Blaschke S, Wessels JT, Müller GA.

(18) Epigenetic control of CIITA expression in leukemic T cellsBiochemical pharmacologySeptember 15, 2004Holling TM, Van der Stoep N, Van den Elsen PJ.

(19) Effects of adipose-derived mesenchymal stem cell conditioned medium on human tenocytes exposed to high glucoseTherapeutic advances in musculoskeletal diseaseJanuary 1, 0001"Trotta MC, Itro A, Lepre CC, Russo M, Guida F, Moretti A, Braile A, Tarantino U, D'Amico M, Toro G."CA, USA), anti-CD45 CD34 (1:100; sc-1178, Santa Cruz; Santa Cruz, CA, USA) and anti-HLA-DR (1:100; sc-18875 Santa Cruz; Santa Cruz, CA, USA) primary human antibodies, diluted in PBS containing 1% BSA and 0.1%

Be the First to Write a Review!

HLA-DR (L243) Antibody

HLA-DR (L243) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (19)

Reviews

HLA-DR (L243) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map